menu
    • menu

    Company profile for Cayman Pharma s.r.o

    Cayman Pharma s.r.o-PSE
    News
    Silexion Appoints Prof. Amnon Peled To Board Of Directors

    10 Dec 2024

    // GLOBENEWSWIRE

    Chemist with a passion for technology

    15 Jan 2021

    // PRESS RELEASE

    Pavel Bartko: One security guard will not solve work safety as a soldier himself in the field. He must have the support of employees

    05 Oct 2020

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Cayman pharma

    Contact Supplier

    Website

    Pharma, Lab & Chemical Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/V7WPzEw9jtQ?si=eVtMOSzxfCL_Ai_m

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.

    Related CompaniesRelated Companies

    About

    Cayman Pharma, a leading European provider of cGMP prostaglandin APIs, was formed in 2006 through the merger of Cayman Chemical and NeraPharm, both with vast expertise in prostaglandin chemistry. With almost 60 years of experience, Cayman Pharma owns and uses a patented route for the prostaglandin core structure and has received GMP approvals from European and US regulatory agencies. The company offers validated GMP routes and regulatory approvals for various therapeutic areas, including fertility, eye care, glaucoma and pulmonary hypertension, enabling the development and market launch of its products.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cayman Pharma s.r.oCzechRepublic Flag
    Country
    Country
    Czech Republic
    Address
    Address
    Práce 657, 277 11, Neratovice
    Telephone
    Telephone
    +420 313033155
    Client Email
    Email
    sales@caymanpharma.cz
    Client Website
    Website
    https://www.caymanpharma.com/home
    Linkedin
    Linkedin
    https://in.linkedin.com/company/cayman-pharma-s-r-o-
    youtube
    YouTube
    http://www.youtube.com/@caymanpharma9856
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-84466.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-8972.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    API Product List

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-54585.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Ophthalmology APIs

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-10065.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Psychedelic APIs

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-61724.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Animal Health APIs

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-24364.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Vascular APIs

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-52276.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    CGMP Services

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-90282.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-36325.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Ionizable Cationic Lipids: From R&D to API

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-60514.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate SUKL

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-81286.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate USKVBL

    read-more

      https://www.pharmacompass.com/pdf/party/content/cayman-pharma-sro-party-content-2864.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Silexion Appoints Prof. Amnon Peled To Board Of Directors
    Silexion Appoints Prof. Amnon Peled To Board Of Directors

    10 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/10/2994560/0/en/Silexion-Therapeutics-Appoints-Renowned-Cancer-Therapeutics-Expert-Prof-Amnon-Peled-to-Board-of-Directors.html

    GLOBENEWSWIRE
    10 Dec 2024
    Share Share
    Chemist with a passion for technology
    Chemist with a passion for technology

    15 Jan 2021

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/chemist-with-a-passion-for-technology-30802.pdf

    PRESS RELEASE
    15 Jan 2021
    Share Share
    Pavel Bartko: One security guard will not solve work safety as a soldier himself in the field. He must have the support of employees
    Pavel Bartko: One security guard will not solve work safety as a soldier himself in the field. He must have the support of employees

    05 Oct 2020

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/pavel-bartko-one-security-guard-will-not-solve-work-safety-as-a-soldier-himself-in-the-field-he-must-have-the-support-of-employees-69499.pdf

    PRESS RELEASE
    05 Oct 2020
    Share Share
    Coronavirus has tested the resilience of companies Ours has survived and we continue to run at full throttle
    Coronavirus has tested the resilience of companies Ours has survived and we continue to run at full throttle

    12 Jun 2020

    // PRESS RELEASE

    https://www.caymanpharma.com/news/459

    PRESS RELEASE
    12 Jun 2020
    Share Share
    Jiří Kratochvíl: Let's not forget that we also have patients without COVID-19
    Jiří Kratochvíl: Let's not forget that we also have patients without COVID-19

    07 May 2020

    // PRESS RELEASE

    https://www.caymanpharma.com/news/451

    PRESS RELEASE
    07 May 2020
    Share Share
    When the electronic time comes to the company
    When the electronic time comes to the company

    27 Mar 2020

    // PRESS RELEASE

    https://www.caymanpharma.com/news/431

    PRESS RELEASE
    27 Mar 2020
    Share Share

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.

    Cayman Update on its Dental Implant candidate KMN-159 for Osseointegration

    Details:

    KMN-159 is a potent, stable, and a highly selective EP4 receptor agonist that stimulates osteogenic activity. It is being evaluated for the treatment of osteoporosis.


    Lead Product(s): KMN-159

    Therapeutic Area: Musculoskeletal Brand Name: KMN-159

    Study Phase: PreclinicalProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable May 04, 2023

    Cayman

    01

    Cayman Pharma s.r.o

    Czech Republic
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothCayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.

    Lead Product(s) : KMN-159

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Preclinical

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Cayman Update on its Dental Implant candidate KMN-159 for Osseointegration

    Details : KMN-159 is a potent, stable, and a highly selective EP4 receptor agonist that stimulates osteogenic activity. It is being evaluated for the treatment of osteoporosis.

    Brand Name : KMN-159

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    May 04, 2023

    Cayman

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Cayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration

    Details:

    The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.


    Lead Product(s): KMN-159,Collagen

    Therapeutic Area: Musculoskeletal Brand Name: KMN-159

    Study Phase: PreclinicalProduct Type: Small molecule

    Sponsor: NIDCR

    Deal Size: $1.7 million Upfront Cash: Undisclosed

    Deal Type: Funding September 16, 2021

    Cayman

    02

    Cayman Chemical Company Inc

    U.S.A
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : KMN-159,Collagen

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Preclinical

    Partner/Sponsor/Collaborator : NIDCR

    Deal Size : $1.7 million

    Deal Type : Funding

    DEALS_DEV arrow-down

    Cayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration

    Details : The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.

    Brand Name : KMN-159

    Molecule Type : Small molecule

    Upfront Cash : Undisclosed

    September 16, 2021

    Cayman

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Cayman Receives SBIR Grant for Alzheimer’s Research

    Details:

    The funding will be used to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.


    Lead Product(s): Antibody

    Therapeutic Area: Neurology Brand Name: Undisclosed

    Study Phase: PreclinicalProduct Type: Large molecule

    Sponsor: SBIR

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Funding October 08, 2020

    Cayman

    03

    Cayman Chemical Company Inc

    U.S.A
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Antibody

    Therapeutic Area : Neurology

    Highest Development Status : Preclinical

    Partner/Sponsor/Collaborator : SBIR

    Deal Size : Undisclosed

    Deal Type : Funding

    DEALS_DEV arrow-down

    Cayman Receives SBIR Grant for Alzheimer’s Research

    Details : The funding will be used to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.

    Brand Name : Undisclosed

    Molecule Type : Large molecule

    Upfront Cash : Undisclosed

    October 08, 2020

    Cayman

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Services

    Discover the service capabilities from this company

    Analytical

    Discover their expertise for : Analytical

    API Manufacturing

    Discover their expertise for : API Manufacturing

    API & Drug Product Development

    Discover their expertise for : API & Drug Product Development

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Contact Cayman Pharma s.r.o and get a quotation

    Cayman Pharma s.r.o is a supplier offers 11 products (APIs, Excipients or Intermediates).

    Find a price of Epoprostenol Sodium bulk with DMF, JDMF offered by Cayman Pharma s.r.o

    Find a price of Latanoprost bulk with DMF, JDMF offered by Cayman Pharma s.r.o

    Find a price of Travoprost bulk with DMF, JDMF offered by Cayman Pharma s.r.o

    Find a price of Bimatoprost bulk with DMF offered by Cayman Pharma s.r.o

    Find a price of Latanoprostene Bunod bulk with DMF offered by Cayman Pharma s.r.o

    Find a price of Tafluprost bulk with DMF offered by Cayman Pharma s.r.o

    Find a price of Cloprostenol Sodium bulk offered by Cayman Pharma s.r.o

    Find a price of Dimethyltryptamine bulk offered by Cayman Pharma s.r.o

    Find a price of Midomafetamine bulk offered by Cayman Pharma s.r.o

    Find a price of Psilocin bulk offered by Cayman Pharma s.r.o

    Find a price of Psilocybine bulk offered by Cayman Pharma s.r.o

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search